Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Triazolam
Drug ID BADD_D02277
Description Withdrawn in the United Kingdom due to risk of psychiatric adverse drug reactions. This drug continues to be available in the U.S. Internationally, triazolam is a Schedule IV drug under the Convention on Psychotropic Substances.
Indications and Usage For the short-term treatment of insomnia.
Marketing Status Prescription; Discontinued
ATC Code N05CD05
DrugBank ID DB00897
KEGG ID D00387
MeSH ID D014229
PubChem ID 5556
TTD Drug ID D0U3LS
NDC Product Code 0009-0017; 55289-787; 67763-128; 0054-4858; 0009-5188; 50742-645; 59762-3718; 50742-646; 71335-1876; 59762-3717; 50090-4733; 12828-0041; 0054-4859; 43063-996; 50090-0522; 42816-0017; 43353-451; 63629-2956
Synonyms Triazolam | U-33,030 | U 33,030 | U33,030 | Halcion | Trilam | Apo-Triazo | Apo Triazo | Gen-Triazolam | Gen Triazolam
Chemical Information
Molecular Formula C17H12Cl2N4
CAS Registry Number 28911-01-5
SMILES CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal pain07.01.05.002--
Abnormal dreams19.02.03.001; 17.15.02.001--Not Available
Aggression19.05.01.0010.001847%Not Available
Agitation17.02.05.012; 19.06.02.0010.005540%
Akinesia17.01.02.0030.002770%Not Available
Alanine aminotransferase increased13.03.01.0030.001847%
Altered state of consciousness19.07.01.003; 17.02.04.0010.009233%Not Available
Amnesia19.20.01.001; 17.03.02.0010.006463%
Anaesthetic complication pulmonary22.02.07.005; 12.02.12.0070.002770%Not Available
Anterograde amnesia19.20.01.005; 17.03.02.005--Not Available
Anxiety19.06.02.0020.004616%
Aspartate aminotransferase13.03.01.032--Not Available
Aspartate aminotransferase increased13.03.01.0060.004616%
Asthenia08.01.01.0010.008310%Not Available
Ataxia17.02.02.001; 08.01.02.004--
Blood albumin13.09.01.012--Not Available
Blood alkaline phosphatase13.04.02.010--Not Available
Blood bilirubin13.03.01.040--Not Available
Blood creatine phosphokinase increased13.04.01.0010.003693%
Blood creatinine13.13.01.020--Not Available
Blood glucose13.02.02.009--Not Available
Blood glucose increased13.02.02.0020.001847%Not Available
Blood pressure decreased13.14.03.0020.001847%Not Available
Bradycardia02.03.02.0020.001847%Not Available
Bradykinesia17.01.02.0040.007386%Not Available
Breast cancer16.10.01.001; 21.05.01.0030.001847%Not Available
Cardiac arrest02.03.04.0010.000482%
Cardiac failure02.05.01.0010.000723%
Chest pain02.02.02.011; 22.02.08.003; 08.01.08.002--Not Available
Cold sweat23.02.03.002; 08.01.03.0240.002770%Not Available
The 1th Page    1 2 3 4 5    Next   Last    Total 7 Pages